Home EEG monitoring for fenfluramine dose in epilepsy
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests if using a small, at-home EEG patch can help doctors adjust the dose of fenfluramine more safely and effectively for people with Dravet syndrome or Lennox-Gastaut syndrome. You may be eligible if you are starting fenfluramine for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Dravet syndrome or Lennox-Gastaut syndrome
- Your doctor has decided to start you on fenfluramine, and you have not taken it before
- You or your caregiver can keep a daily seizure diary, for example using a phone app
- You do not have any serious heart, blood vessel, or other health problems that would make the study unsafe
- You are older than 3 years old and not on certain medications that interact with fenfluramine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how brain wave patterns change when children and young adults with Lennox-Gastaut Syndrome (a severe seizure disorder) take fenfluramine, a medication that helps reduce drop seizures. Researchers will use EEG (brain wave recordings) to understand how this treatment affects the brain.
This trial tests the safety of a medicine called fenfluramine for children under 2 years old with Dravet syndrome. It aims to see if fenfluramine can help control seizures in very young children.
This study tests a new brain stimulation device that adjusts treatment based on your sleep patterns to reduce seizures in Lennox-Gastaut syndrome. The device may help people whose seizures haven't been controlled by medications alone.
This study tests whether the drug fenfluramine can reduce the risk of sudden unexpected death (SUDEP) in people with Dravet syndrome who have generalized convulsive seizures. It aims to see if a lower dose can still prevent seizures and protect the heart and breathing during a seizure.
This study tests using a small, home-based EEG device to monitor brain activity over several weeks in people with hard-to-control seizures, rare epilepsies, or developmental and epileptic encephalopathies. The goal is to see if this method can better track seizures and improve care.
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
Hear when a new Lennox Gastaut Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.